Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$276M |
| 2 |
NextEra Energy
NEE
|
+$275M |
| 3 |
Progressive
PGR
|
+$241M |
| 4 |
Kenvue
KVUE
|
+$228M |
| 5 |
PepsiCo
PEP
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$402M |
| 2 |
Zimmer Biomet
ZBH
|
+$395M |
| 3 |
NEE.PRQ
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
|
+$395M |
| 4 |
Amgen
AMGN
|
+$375M |
| 5 |
Willis Towers Watson
WTW
|
+$346M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.75% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 10.76% |
| 4 | Industrials | 9.67% |
| 5 | Consumer Discretionary | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
BioMarin Pharmaceuticals
BMRN
$11.5B
| $50.1M | 0.03% |
566,242
-269,989
| -32% | -$24M |
|
477
Kroger
KR
$34.8B
| $50.1M | 0.03% |
1,119,396
-82,877
| -7% | -$3.9M |
|
478
Berkshire Hathaway Class A
BRK.A
$1.07T
| $50M | 0.03% |
94
+1
| +1% | +$539K |
|
|
DAWN
479
DELISTED
Day One Biopharmaceuticals
DAWN
| $49.9M | 0.03% |
4,067,332
+1,664
| +0% | +$21.7K |
|
|
NVO
480
Novo Nordisk
NVO
$216B
| $49.8M | 0.03% |
547,438
-35,480
| -6% | -$3.13M |
|
481
M/I Homes
MHO
$3.83B
| $49.4M | 0.03% |
587,915
-168,214
| -22% | -$15.5M |
|
482
Church & Dwight Co
CHD
$23.1B
| $49.4M | 0.03% |
538,622
-5,323
| -1% | -$510K |
|
483
Colliers International
CIGI
$4.98B
| $49.3M | 0.03% |
518,092
+463,077
| +842% | +$49.7M |
|
|
CBAY
484
DELISTED
Cymabay Therapeutics
CBAY
| $49.3M | 0.03% |
3,307,915
+35,907
| +1% | +$476K |
|
485
McKesson
MCK
$98.5B
| $49.3M | 0.03% |
113,368
+37,515
| +49% | +$15.8M |
|
486
iShares MSCI EAFE ETF
EFA
$76.4B
| $49M | 0.02% |
711,527
+35,775
| +5% | +$2.56M |
|
487
3M
MMM
$89B
| $48.8M | 0.02% |
623,334
-24,942
| -4% | -$2.14M |
|
488
Vaxcyte
PCVX
$7.89B
| $48.7M | 0.02% |
955,935
+203,536
| +27% | +$10M |
|
489
Hershey
HSY
$35.4B
| $48.7M | 0.02% |
243,297
-50,959
| -17% | -$11.4M |
|
490
Capri Holdings
CPRI
$1.77B
| $48M | 0.02% |
913,016
+9,157
| +1% | +$415K |
|
491
Spire
SR
$4.92B
| $47.4M | 0.02% |
837,364
+1,464
| +0.2% | +$88.8K |
|
|
SEE
492
DELISTED
Sealed Air
SEE
| $47.3M | 0.02% |
1,438,012
+6,684
| +0.5% | +$258K |
|
493
Cummins
CMI
$91.7B
| $46.7M | 0.02% |
204,454
-22,627
| -10% | -$5.46M |
|
494
Kimberly-Clark
KMB
$36.4B
| $46.7M | 0.02% |
386,476
-17,111
| -4% | -$2.21M |
|
|
RVNC
495
DELISTED
Revance Therapeutics, Inc.
RVNC
| $46.3M | 0.02% |
4,037,561
+1,775,082
| +78% | +$34.1M |
|
496
Stantec
STN
$7.69B
| $46.2M | 0.02% |
711,950
-430,305
| -38% | -$28.6M |
|
497
TriCo Bancshares
TCBK
$1.85B
| $46.1M | 0.02% |
1,440,778
| – | – |
|
498
PTC Therapeutics
PTCT
$6.37B
| $46.1M | 0.02% |
2,057,233
-1,254,671
| -38% | -$46.7M |
|
499
Vontier
VNT
$4.33B
| $46M | 0.02% |
1,488,691
+76,353
| +5% | +$2.35M |
|
500
Evercore
EVR
$13.1B
| $45.8M | 0.02% |
332,171
-11,557
| -3% | -$1.57M |
|
Similar funds
Franklin Resources's Q3 2023 Portfolio in Review
As of Q3 2023, Franklin Resources held 2,849 positions worth $197B, down 6.4% from $210B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Franklin Resources withdrew a net $6.91B in Q3 2023, closing 192 positions and reducing 1,252 holdings. Its most notable exit was NextEra Energy, Inc. 6.219% Corporate Units, an estimated $395M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Franklin Resources opened a new position in Apollo Global Management Series A worth $132M.
- Franklin Resources's largest Q3 2023 buy was Apollo Global Management Series A: 2,400,100 shares worth $132M.
- Franklin Resources added most to Merck in Q3 2023, an estimated $276M increase.
- Franklin Resources's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $402M.
- Franklin Resources fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q3 2023, selling an estimated $395M.
- Franklin Resources's ten largest holdings make up 18% of its $197B portfolio in Q3 2023.
- Franklin Resources opened 128 new positions and closed 192 in Q3 2023.
- Franklin Resources's portfolio value fell 6.4% quarter-over-quarter to $197B.
Based on Franklin Resources's 13F filing for Q3 2023, filed 13 Nov 2023.